BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26681273)

  • 1. Tumor volume as a predictor of survival in human papillomavirus-positive oropharyngeal cancer.
    Davis KS; Lim CM; Clump DA; Heron DE; Ohr JP; Kim S; Duvvuri U; Johnson JT; Ferris RL
    Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E1613-7. PubMed ID: 26681273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-category remains an important prognostic factor for oropharyngeal carcinoma in the era of human papillomavirus.
    Mackenzie P; Pryor D; Burmeister E; Foote M; Panizza B; Burmeister B; Porceddu S
    Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):643-7. PubMed ID: 25001635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-free survival after salvage therapy for recurrent oropharyngeal squamous cell carcinoma.
    Joseph AW; Guo T; Hur K; Xie Y; Yin L; Califano JA; Ha PK; Quon H; Richmon JD; Eisele DW; Agrawal N; Fakhry C
    Head Neck; 2016 Apr; 38 Suppl 1():E1501-9. PubMed ID: 26558328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor volume as a prognostic marker in p16-positive and p16-negative oropharyngeal cancer patients treated with definitive intensity-modulated radiotherapy.
    Carpén T; Saarilahti K; Haglund C; Markkola A; Tarkkanen J; Hagström J; Mattila P; Mäkitie A
    Strahlenther Onkol; 2018 Aug; 194(8):759-770. PubMed ID: 29774396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staging and treatment of oropharyngeal cancer in the human papillomavirus era.
    Ward MJ; Mellows T; Harris S; Webb A; Patel NN; Cox HJ; Piper K; Ottensmeier CH; Thomas GJ; King EV
    Head Neck; 2015 Jul; 37(7):1002-13. PubMed ID: 24753272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era.
    Keane FK; Chen YH; Neville BA; Tishler RB; Schoenfeld JD; Catalano PJ; Margalit DN
    Cancer; 2015 Aug; 121(15):2594-602. PubMed ID: 25873094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-Pk
    Weaver AN; Cooper TS; Wei S; Carroll WR; Rosenthal EL; Yang ES
    Head Neck; 2017 Feb; 39(2):206-214. PubMed ID: 27507640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nodal response after 46 Gy of intensity-modulated radiotherapy is associated with human papillomavirus-related oropharyngeal carcinoma.
    Dronkers EAC; Koljenovic S; Verduijn GM; Baatenburg de Jong RJ; Hardillo JAU
    Laryngoscope; 2018 Oct; 128(10):2333-2340. PubMed ID: 29521420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH; Sinha P
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging.
    Rios Velazquez E; Hoebers F; Aerts HJ; Rietbergen MM; Brakenhoff RH; Leemans RC; Speel EJ; Straetmans J; Kremer B; Lambin P
    Radiother Oncol; 2014 Dec; 113(3):324-30. PubMed ID: 25443497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.
    He YX; Wang Y; Cao PF; Shen L; Zhao YJ; Zhang ZJ; Chen DM; Yang TB; Huang XQ; Qin Z; Dai YY; Shen LF
    Chin J Cancer; 2016 Nov; 35(1):96. PubMed ID: 27852284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relevance of the lymph node ratio as predictor of prognosis is higher in HPV-negative than in HPV-positive oropharyngeal squamous cell carcinoma.
    Meyer MF; Meinrath J; Seehawer J; Lechner A; Odenthal M; Quaas A; Semrau R; Huebbers CU; Marnitz S; Büttner R; Beutner D
    Clin Otolaryngol; 2018 Feb; 43(1):192-198. PubMed ID: 28714274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse effect of smoking on prognosis in human papillomavirus-associated oropharyngeal carcinoma.
    Liskamp CP; Janssens GO; Bussink J; Melchers WJ; Kaanders JH; Verhoef CG
    Head Neck; 2016 Dec; 38(12):1780-1787. PubMed ID: 27248701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ki67 Expression has Prognostic Significance in Relation to Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma.
    Liu J; Zhang M; Rose B; Veillard AS; Jones D; Zhang X; Soon Lee C; Milross C; Hong A
    Ann Surg Oncol; 2015; 22(6):1893-900. PubMed ID: 25404475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of surgically treated human papillomavirus-related oropharyngeal squamous cell carcinoma with N3 disease.
    Zenga J; Haughey BH; Jackson RS; Adkins DR; Aranake-Chrisinger J; Bhatt N; Gay HA; Kallogjeri D; Martin EJ; Moore EJ; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
    Laryngoscope; 2017 Sep; 127(9):2033-2037. PubMed ID: 28008626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of the lymph node ratio in oropharyngeal carcinoma stratified for HPV-status.
    Jacobi C; Rauch J; Hagemann J; Lautz T; Reiter M; Baumeister P
    Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):515-524. PubMed ID: 29204919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Squamous cell carcinoma of unknown primary of the head and neck: Favorable prognostic factors comparable to those in oropharyngeal cancer.
    Zhou MJ; van Zante A; Lazar AA; Groppo ER; Garsa AA; Ryan WR; El-Sayed IH; Eisele DW; Yom SS
    Head Neck; 2018 May; 40(5):904-916. PubMed ID: 29210145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic impact of human papillomavirus status following treatment failure in oropharyngeal cancer.
    Dave E; Ozbek U; Gupta V; Genden E; Miles B; Teng M; Posner M; Misiukiewicz K; Bakst RL
    PLoS One; 2017; 12(7):e0181108. PubMed ID: 28732044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma.
    Nichols AC; Faquin WC; Westra WH; Mroz EA; Begum S; Clark JR; Rocco JW
    Otolaryngol Head Neck Surg; 2009 Feb; 140(2):228-34. PubMed ID: 19201294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of comorbidity and anemia in patients with oropharyngeal cancer primarily treated with surgery in the human papillomavirus era.
    Baumeister P; Rauch J; Jacobi C; Kisser U; Betz C; Becker S; Reiter M
    Head Neck; 2017 Jan; 39(1):7-16. PubMed ID: 27385398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.